'Showdown' Looms As J&J Pursues Rebates In 340B Program
Johnson & Johnson's plan to abandon upfront discounts and instead offer rebates for two popular medications under the 340B drug pricing law would fundamentally alter how the program has worked for...To view the full article, register now.
Already a subscriber? Click here to view full article